Analyst Price Target Update for Mycronic
Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.
What's in the News
- Mycronic secured an order for three mask writers from an existing customer in Asia. The order is valued at USD 48-52 million, with deliveries scheduled between Q2 2026 and Q1 2027 (Key Developments).
- The company received an additional order for an SLX mask writer from an existing customer in Asia. This order is valued at USD 5-7 million, with delivery planned for the second quarter of 2026 (Key Developments).
- Mycronic announced another SLX mask writer order from an existing customer in Asia. The order is valued at USD 3-5 million, with net sales recognized in the current quarter (Key Developments).
Valuation Changes
- Consensus Analyst Price Target: Increased from SEK 207.00 to SEK 216.67.
- Discount Rate: Increased slightly from 6.24% to 6.27%.
- Revenue Growth: Projected growth has more than doubled, rising from 1.28% to 2.74%.
- Net Profit Margin: Decreased from 20.87% to 18.10%.
- Future P/E: Increased from 27.75x to 32.39x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.